Compounds > lopinavir
Page last updated: 2024-08-26

lopinavir and Electrocardiogram QT Prolonged

lopinavir has been researched along with Electrocardiogram QT Prolonged in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's19 (100.00)2.80

Authors

AuthorsStudies
Cevenini, F; Fallani, E; Lazzerini, PE; Saponara, S; Verdini, A1
Ackerman, MJ; Friedman, PA; Giudicessi, JR; Noseworthy, PA1
Habibzadeh, P; Lankarani, KB; Moghadami, M1
Fenioux, C; Funck-Brentano, C; Gligorov, J; Gougis, P; Solas, C; Spano, JP; Veyri, M1
Carron, J; Hussein, H; Kennedy, M; McAdam, B; Sharif, Z; Sheahan, R1
Chen, X; Chu, J; Liu, Y; Wang, J; Wang, Y; Zhu, S1
Cameli, M; Cameli, P; Franchi, F; Mandoli, GE; Menci, D; Mondillo, S; Sciaccaluga, C; Sisti, N; Valente, S1
Ding, C; García, JA; García-Abellán, J; García-Pachón, E; Guillén, L; Gutiérrez, F; Masiá, M; Mora, A; Padilla, S; Telenti, G1
Grundmark, B; Vidlin, SH; Watson, S; Zekarias, A1
Drici, MD; Fresse, A; Gérard, A; Lepelley, M; Rocher, F; Romani, S; Salem, JE; Viard, D1
Aureau, I; Bernard, N; Bonnet, F; Bouchet, S; Contis, A; Hessamfar, M; Lahouati, M; Lapoirie, J; Meriglier, E; Pedeboscq, S; Rivoisy, C; Sacher, F; Sacristan, B; Vandenhende, MA1
Battegay, M; Leuppi-Taegtmeyer, A; Marzolini, C; Sendi, P; Stader, F; Stoeckle, M1
Dingding, Q; Jiangfang, L; Yujia, W; Zequn, Z1
Capuzzi, E; Clerici, M; Colmegna, F; D'Amico, E; Dakanalis, A; di Giacomo, E; Marcatili, M; Stefana, A1
Andy Ko, TY; Chen, LS; Koh, KT; Ling, HS; Pang, IX; Sia Tonnii, LL; Wong, TC1
Brañez-Condorena, A; Diaz-Arocutipa, C; Hernandez, AV1
Benito-González, T; Borrego-Rodríguez, J; Del Castillo-García, S; Echarte-Morales, J; Fernández-Vázquez, F; Flores-Vergara, G; García-Bergel, R; Iglesias-Garriz, I; Maniega, CG; Menéndez-Suárez, P; Minguito-Carazo, C; Palacios-Echavarren, C; Prieto-González, S; Rodríguez-Santamarta, M; Sánchez-Muñoz, E1
Bao, Y; Chen, Z; Ding, J; Feng, Y; Guan, H; Li, H; Liu, W; Wang, X; Zhou, Z1
Budiman, F; Ivan, I; Juliawati, DJ; Ridjab, DA1

Reviews

5 review(s) available for lopinavir and Electrocardiogram QT Prolonged

ArticleYear
Clinical guidance for navigating the QTc-prolonging and arrhythmogenic potential of pharmacotherapy during the COVID-19 pandemic.
    Irish journal of medical science, 2021, Volume: 190, Issue:1

    Topics: Anti-Bacterial Agents; Antiviral Agents; Azithromycin; COVID-19 Drug Treatment; Drug Combinations; Electrocardiography; Enzyme Inhibitors; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Magnesium; Pandemics; Potassium; Practice Guidelines as Topic; Risk Assessment; Risk Factors; Ritonavir; SARS-CoV-2; Torsades de Pointes

2021
COVID-19 and the burning issue of drug interaction: never forget the ECG.
    Postgraduate medical journal, 2021, Volume: 97, Issue:1145

    Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Antiviral Agents; Arrhythmias, Cardiac; Chloroquine; COVID-19 Drug Treatment; Drug Combinations; Drug Interactions; Electrocardiography; Heart Failure; Humans; Hydroxychloroquine; Hypoxia; Inflammation; Long QT Syndrome; Lopinavir; Myocarditis; Myocardium; Precipitating Factors; Receptors, Interleukin-6; Respiratory Distress Syndrome; Ribavirin; Ritonavir; SARS-CoV-2; Water-Electrolyte Imbalance

2021
Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel.
    European journal of pharmacology, 2021, Feb-15, Volume: 893

    Topics: Azithromycin; Chloroquine; COVID-19; COVID-19 Drug Treatment; Drug Combinations; ERG1 Potassium Channel; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Off-Label Use; Ritonavir

2021
QTc prolongation in COVID-19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta-analysis.
    Pharmacoepidemiology and drug safety, 2021, Volume: 30, Issue:6

    Topics: Azithromycin; Chloroquine; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Observational Studies as Topic; Ritonavir

2021
Current evidence for the risk of PR prolongation, QRS widening, QT prolongation, from lopinavir, ritonavir, atazanavir, and saquinavir: A systematic review.
    Medicine, 2021, Aug-06, Volume: 100, Issue:31

    Topics: Adult; Atazanavir Sulfate; Cytochrome P-450 CYP3A Inhibitors; Drug Therapy, Combination; Electrocardiography; Humans; Long QT Syndrome; Lopinavir; Ritonavir; Saquinavir

2021

Other Studies

14 other study(ies) available for lopinavir and Electrocardiogram QT Prolonged

ArticleYear
Off-Label Use of Hydroxychloroquine in COVID-19: Analysis of Reports of Suspected Adverse Reactions From the Italian National Network of Pharmacovigilance.
    Journal of clinical pharmacology, 2022, Volume: 62, Issue:5

    Topics: Azithromycin; COVID-19 Drug Treatment; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Off-Label Use; Pharmacovigilance; Ritonavir

2022
Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19).
    Mayo Clinic proceedings, 2020, Volume: 95, Issue:6

    Topics: Anti-Infective Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Death, Sudden, Cardiac; Drug Combinations; Drug Monitoring; Drug Repositioning; Electrocardiography; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Pandemics; Pneumonia, Viral; Risk Adjustment; Ritonavir; SARS-CoV-2; Torsades de Pointes

2020
The effect of potential therapeutic agents on QT interval in patients with COVID-19 Infection: The importance of close monitoring and correction of electrolytes.
    Medical hypotheses, 2020, Volume: 143

    Topics: Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Monitoring; Heart Conduction System; Humans; Hydroxychloroquine; Hypokalemia; Long QT Syndrome; Lopinavir; Magnesium; Pandemics; Pneumonia, Viral; Potassium; Retrospective Studies; Ritonavir; SARS-CoV-2

2020
Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use?
    European journal of cancer (Oxford, England : 1990), 2020, Volume: 136

    Topics: Amides; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Immunological; Antiviral Agents; Betacoronavirus; Chemical and Drug Induced Liver Injury; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytochrome P-450 Enzyme System; Drug Combinations; Drug Interactions; Histone Deacetylase Inhibitors; Humans; Hydroxychloroquine; Immunosuppression Therapy; Kidney Diseases; Long QT Syndrome; Lopinavir; Neoplasms; Pandemics; Pneumonia, Viral; Poly(ADP-ribose) Polymerase Inhibitors; Proteasome Inhibitors; Protein Kinase Inhibitors; Pyrazines; Ritonavir; SARS-CoV-2

2020
QTc prolongation during antiviral therapy in two COVID-19 patients.
    Journal of clinical pharmacy and therapeutics, 2020, Volume: 45, Issue:5

    Topics: Antiviral Agents; COVID-19 Drug Treatment; Drug Combinations; Drug Interactions; Electrocardiography; Female; Humans; Long QT Syndrome; Lopinavir; Middle Aged; Ritonavir; Sex Factors

2020
Predictive factors for cardiac conduction abnormalities with hydroxychloroquine-containing combinations for COVID-19.
    International journal of antimicrobial agents, 2020, Volume: 56, Issue:4

    Topics: Aged; Anti-Infective Agents; Azithromycin; Betacoronavirus; Biomarkers; Coronavirus Infections; COVID-19; Disease Progression; Drug Combinations; Female; Humans; Hydroxychloroquine; Intensive Care Units; Long QT Syndrome; Lopinavir; Lymphocytes; Male; Middle Aged; Neutrophils; Pandemics; Pneumonia, Viral; Prognosis; Proportional Hazards Models; Retrospective Studies; Ritonavir; SARS-CoV-2; Treatment Outcome; Troponin I

2020
Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports.
    Drug safety, 2020, Volume: 43, Issue:12

    Topics: Abdominal Pain; Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Chemical and Drug Induced Liver Injury; Chloroquine; COVID-19 Drug Treatment; Databases, Pharmaceutical; Diarrhea; Drug Combinations; Drug Eruptions; Drug Repositioning; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Male; Nausea; Oseltamivir; Ritonavir; Sex Distribution; Sex Factors; Vomiting

2020
Spontaneous reported cardiotoxicity induced by lopinavir/ritonavir in COVID-19. An alleged past-resolved problem.
    International journal of cardiology, 2021, 02-01, Volume: 324

    Topics: Aged; Aged, 80 and over; Cardiotoxicity; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Electrocardiography; Female; France; HIV Protease Inhibitors; Humans; Long QT Syndrome; Lopinavir; Male; Middle Aged; Pharmacovigilance; Potassium Channel Blockers; Ritonavir

2021
Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection.
    The Journal of antimicrobial chemotherapy, 2021, 01-19, Volume: 76, Issue:2

    Topics: Antiviral Agents; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Darunavir; Drug Therapy, Combination; Electrocardiography; France; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; SARS-CoV-2; Severity of Illness Index; Treatment Outcome

2021
Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19.
    Drug safety, 2021, Volume: 44, Issue:2

    Topics: COVID-19 Drug Treatment; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Long QT Syndrome; Lopinavir; Male; Pharmaceutical Preparations; SARS-CoV-2; Sex Characteristics

2021
Consultation psychiatry in COVID-19 patients: Lopinavir/ritonavir interactions with main psychiatric drugs.
    Psychiatry and clinical neurosciences, 2021, Volume: 75, Issue:4

    Topics: COVID-19 Drug Treatment; Drug Interactions; Humans; Hypericum; Long QT Syndrome; Lopinavir; Psychiatry; Psychotropic Drugs; Referral and Consultation; Ritonavir; Viral Protease Inhibitors

2021
Smartphone electrocardiogram for QT interval monitoring in Coronavirus Disease 2019 (COVID-19) patients treated with Hydroxychloroquine.
    The Medical journal of Malaysia, 2021, Volume: 76, Issue:2

    Topics: Adult; Aged; Antiviral Agents; COVID-19 Drug Treatment; Drug Combinations; Electrocardiography; Enzyme Inhibitors; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Male; Middle Aged; Mobile Applications; Ritonavir; Smartphone

2021
QT Interval Monitoring with Handheld Heart Rhythm ECG Device in COVID-19 Patients.
    Global heart, 2021, 06-08, Volume: 16, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiviral Agents; Azithromycin; COVID-19 Drug Treatment; Drug Combinations; Electrocardiography; Enzyme Inhibitors; Feasibility Studies; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Male; Middle Aged; Point-of-Care Systems; Prospective Studies; Reproducibility of Results; Ritonavir; SARS-CoV-2

2021
Corrected QT interval in hospitalized patients with coronavirus disease 2019: Focus on drugs therapy.
    Medicine, 2021, Jul-16, Volume: 100, Issue:28

    Topics: Aged; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Drugs, Chinese Herbal; Electrocardiography; Female; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Indoles; Interferons; Long QT Syndrome; Lopinavir; Male; Middle Aged; Odds Ratio; Quinolones; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index

2021